These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Evidence of human thrombomodulin domain as a novel angiogenic factor. Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Wood JM Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930 [TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production. Akita S; Daian T; Ishihara H; Fujii T; Akino K J Dermatol Sci; 2004 Oct; 36(1):11-23. PubMed ID: 15488701 [TBL] [Abstract][Full Text] [Related]
10. In vivo growth stimulation of collagen gel embedded normal human and mouse primary mammary epithelial cells. Popnikolov NK; Yang J; Guzman RC; Swanson SM; Thordarson G; Collins G; Talamantes F; Nandi S J Cell Physiol; 1995 Apr; 163(1):51-60. PubMed ID: 7896900 [TBL] [Abstract][Full Text] [Related]
11. Bioactivity of small intestinal submucosa and oxidized regenerated cellulose/collagen. Nihsen ES; Johnson CE; Hiles MC Adv Skin Wound Care; 2008 Oct; 21(10):479-86. PubMed ID: 18836327 [TBL] [Abstract][Full Text] [Related]
12. In vivo growth factor treatment of degenerated intervertebral discs. Walsh AJ; Bradford DS; Lotz JC Spine (Phila Pa 1976); 2004 Jan; 29(2):156-63. PubMed ID: 14722406 [TBL] [Abstract][Full Text] [Related]
13. Differential role of platelet granular mediators in angiogenesis. Brill A; Elinav H; Varon D Cardiovasc Res; 2004 Aug; 63(2):226-35. PubMed ID: 15249180 [TBL] [Abstract][Full Text] [Related]
14. Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells. Mishima Y; Terui Y; Sugimura N; Matsumoto-Mishima Y; Rokudai A; Kuniyoshi R; Hatake K Cancer Sci; 2007 Mar; 98(3):364-72. PubMed ID: 17270026 [TBL] [Abstract][Full Text] [Related]
15. Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis. Wilasrusmee C; Yusupov I; Ondocin P; Bruch D; Kittur S; Wilasrusmee S; Kittur DS Int Angiol; 2005 Dec; 24(4):372-9. PubMed ID: 16355096 [TBL] [Abstract][Full Text] [Related]
16. A versatile in vivo chamber angiogenesis assay for measuring anti-angiogenic activity in mice. Kragh M; Hjarnaa PJ; Bramm E; Binderup L Oncol Rep; 2004 Feb; 11(2):303-7. PubMed ID: 14719059 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Rofstad EK; Halsør EF Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309 [TBL] [Abstract][Full Text] [Related]
18. A novel in vitro assay for human angiogenesis. Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044 [TBL] [Abstract][Full Text] [Related]
20. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]